UBS Maintains Neutral on enGene Holdings, Raises Price Target to $10
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Colin Bristow maintains enGene Holdings (NASDAQ:ENGN) with a Neutral and raises the price target from $4 to $10.
UBS analyst Colin Bristow maintains enGene Holdings (NASDAQ:ENGN) with a Neutral and raises the price target from $4 to $10.